ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2019, Vol. 28 ›› Issue (4): 374-378.DOI: 10.3969/j.issn.1006-298X.2019.04.016

• 论文 • 上一篇    下一篇

慢性肾脏病患者早期绝经

  

  • 出版日期:2019-08-31 发布日期:2019-10-11

Menopause and chronic kidney disease

  • Online:2019-08-31 Published:2019-10-11

摘要:

绝经指的是在排卵停止后月经永久停止。由于激素替代治疗或肾移植术后月经可恢复,所以传统的绝经定义并不适用于慢性肾脏病(CKD)患者。CKD患者绝经年龄提前,普遍认为与下丘脑垂体性腺轴破坏有关。绝经常伴随血管舒缩症状,CKD患者血管舒缩症状发生率较低,激素替代治疗可有效缓解症状。与绝经前相比,CKD患者绝经后心血管事件及骨折疏松风险增加。由于缺乏充分的证据,不建议CKD患者使用激素替代治疗预防心血管事件。目前缺乏针对CKD 4~5D期绝经后骨质疏松疗效/不良反应的前瞻性纵向临床试验。

关键词: 绝经, 慢性肾脏病, 激素替代治疗, 骨质疏松

Abstract:

Menopause refers to the permanent cessation of menstruation after ovulation stops. Since menstruation can be restored after hormone replacement therapy or kidney transplantation,the traditional definition of menopause does not apply to patients with chronic kidney disease (CKD). The age of menopause in patients with CKD is advanced,and it is generally believed that it is related to destruction of hypothalamicpituitarygonadal axis. Infrequently associated with vasomotor symptoms,the incidence of vasomotor symptoms in CKD patients is low,and hormone replacement therapy can effectively relieve symptoms. Compared with the premenopausal,postmenopausal patients with CKD increases the risk of cardiovascular events and osteoporosis fractures. Due to the lack of sufficient evidence,CKD patients are not advised to use hormone replacement therapy to prevent cardiovascular events. There is currently a lack of prospective longitudinal clinical trials for the efficacy/side effects of CKD 4~5D postmenopausal osteoporosis patients.

Key words: menopause, chronic kidney disease, hormone replacement therapy, osteoporosis